HomeNews & BlogBlog
Caffeine is among the most widely consumed psychoactive substances globally, yet its metabolic fate in the human body follows a distinctive "three-stage leap" pattern. This article systematically describes the first-stage transition in which caffeine undergoes N-3 demethylation catalyzed primarily by hepatic cytochrome P450 1A2 (CYP1A2), generating paraxanthine (1,7-dimethylxanthine, approximately 70–84% of total metabolism).
View More
Discover how patented Urolithin A Choline Salt Type A dramatically improves solubility and bioavailability, offering a next-generation solution for healthy aging, muscle performance, and mitochondrial health.
View More
If you pour a cup of coffee into your mouth, do you think the main character has already taken the stage? In reality, thetruly exciting "show" has only just begun. Once caffeine enters the human body, it does not complete its mission inisolation; instead, it performs like a meticulously choreographed metabolic relay race-caffeine is merely the first runnerat the starting gun, while paraxanthine is the one that seizes the torch and sprints to the finish line. As for theobromineand theophyline, they are more like pacemaking teammates: they are on the track, but they do not ultimately determinethe race outcome.
View More
Berberine, the principal bioactive constituent of Coptis chinensis (Huanglian) and Phellodendron amurense (Huangbai), exhibits a broad spectrum of pharmacological activities including hypoglycemic, hypolipidemic, and anti-inflammatory effects. However, its clinical utility has been severely constrained by an oral bioavailability of less than 1%. This article introduces berberine–ascorbate salt, a novel salt form engineered via counterion substitution, in which L-ascorbic acid (vitamin C) serves as the counterion. Driven by a favorable ΔpKa of 7.33, the proton-transfer reaction yields a highly water-soluble ion pair, increasing aqueous solubility approximately 100-fold at 37 °C and elevating the plasma peak concentration (Cmax) by 5–7-fold in rat pharmacokinetic studies. We systematically review the molecular mechanism, solubility characteristics, in vivo absorption pathway, and prospective health applications of this salt-form engineering breakthrough, and discuss how it overcomes the century-old absorption barrier of berberine. Keywords: berberine; ascorbic acid; salt formation; bioavailability; solubility; pharmaceutical solid-state chemistry; P-glycoprotein
View More
